Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Orexin receptor type 2 | ||
Ligand | BDBM386137 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Measurement of Orexin Type 2 Receptor Agonist Activity | ||
EC50 | 39.0±n/a nM | ||
Citation | Fujimoto, T; Rikimaru, K; Sugimoto, H; Matsumoto, T Substituted piperidine compound and use thereof US Patent US10287305 Publication Date 5/14/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Orexin receptor type 2 | |||
Name: | Orexin receptor type 2 | ||
Synonyms: | HCRTR2 | Hypocretin receptor type 2 | OX2R_HUMAN | Orexin receptor type 2 (OR 2) | Orexin receptor type 2 (OR-2) | Orexin receptor type 2 (OX2) | Orexin receptor type 2 (OX2R) | Orexin receptor type 2 (OxR2) | Ox-2-R | Ox2-R | ||
Type: | Protein | ||
Mol. Mass.: | 50710.53 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O43614 | ||
Residue: | 444 | ||
Sequence: |
| ||
BDBM386137 | |||
n/a | |||
Name | BDBM386137 | ||
Synonyms: | N-((2R,3S)-2-(((cis-4- isopropylcyclohexyl)oxy)methyl)-1-((3- oxocyclobutyl)carbonyl)piperidin-3- yl)methanesulfonamide | US10287305, Example 91 | US10508083, Example 91 | US11292766, Example 91 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H36N2O5S | ||
Mol. Mass. | 428.586 | ||
SMILES | CC(C)[C@@H]1CC[C@@H](CC1)OC[C@H]1[C@H](CCCN1C(=O)C1CC(=O)C1)NS(C)(=O)=O |r,wU:3.2,6.9,11.11,12.26,(-6,3.08,;-4.67,3.85,;-4.67,5.39,;-3.33,3.08,;-3.33,1.54,;-2,.77,;-.67,1.54,;-.67,3.08,;-2,3.85,;.67,.77,;.67,-.77,;2,-1.54,;3.33,-.77,;4.67,-1.54,;4.67,-3.08,;3.33,-3.85,;2,-3.08,;.67,-3.85,;.67,-5.39,;-.67,-3.08,;-1.07,-1.59,;-2.55,-1.99,;-3.89,-1.22,;-2.15,-3.48,;3.33,.77,;4.67,1.54,;6,.77,;3.9,2.87,;5.44,2.87,)| | ||
Structure |